Implantable Drug Delivery Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB504243868

Publication Date:

April 9, 2024

Pages:

116

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Implantable drug delivery devices are an alternative system that can achieve effective delivery with lower drug concentrations, and as a result, minimise side-effects whilst increasing patient compliance.
The global market for Implantable Drug Delivery Devices was estimated to be worth US$ 468.4 million in 2023 and is forecast to a readjusted size of US$ 670.7 million by 2030 with a CAGR of 5.2% during the forecast period 2024-2030
BD, B.Braun, AngioDynamics, Smiths Medical and Teleflex, etc. are the leading products in the international market, accounting for 85.5% of the global market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Implantable Drug Delivery Devices, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Implantable Drug Delivery Devices by region & country, by Type, and by Application.
The Implantable Drug Delivery Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Implantable Drug Delivery Devices.
Market Segmentation
By Company
BD
B.Braun
AngioDynamics
Smiths Medical
Teleflex
Cook Medical
Fresenius
Vygon
PFM Medical
Districlass
Linhwa
Segment by Type:
Titanium Drug Delivery System
Plastic Drug Delivery System
Segment by Application
Intravenous Chemotherapy
Nutrition Support Therapy
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Implantable Drug Delivery Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Implantable Drug Delivery Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Implantable Drug Delivery Devices in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Implantable Drug Delivery Devices Product Introduction
1.2 Global Implantable Drug Delivery Devices Market Size Forecast
1.2.1 Global Implantable Drug Delivery Devices Sales Value (2019-2030)
1.2.2 Global Implantable Drug Delivery Devices Sales Volume (2019-2030)
1.2.3 Global Implantable Drug Delivery Devices Sales Price (2019-2030)
1.3 Implantable Drug Delivery Devices Market Trends & Drivers
1.3.1 Implantable Drug Delivery Devices Industry Trends
1.3.2 Implantable Drug Delivery Devices Market Drivers & Opportunity
1.3.3 Implantable Drug Delivery Devices Market Challenges
1.3.4 Implantable Drug Delivery Devices Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Implantable Drug Delivery Devices Players Revenue Ranking (2023)
2.2 Global Implantable Drug Delivery Devices Revenue by Company (2019-2024)
2.3 Global Implantable Drug Delivery Devices Players Sales Volume Ranking (2023)
2.4 Global Implantable Drug Delivery Devices Sales Volume by Company Players (2019-2024)
2.5 Global Implantable Drug Delivery Devices Average Price by Company (2019-2024)
2.6 Key Manufacturers Implantable Drug Delivery Devices Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Implantable Drug Delivery Devices Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Implantable Drug Delivery Devices
2.9 Implantable Drug Delivery Devices Market Competitive Analysis
2.9.1 Implantable Drug Delivery Devices Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Implantable Drug Delivery Devices Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Implantable Drug Delivery Devices as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Titanium Drug Delivery System
3.1.2 Plastic Drug Delivery System
3.2 Global Implantable Drug Delivery Devices Sales Value by Type
3.2.1 Global Implantable Drug Delivery Devices Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Implantable Drug Delivery Devices Sales Value, by Type (2019-2030)
3.2.3 Global Implantable Drug Delivery Devices Sales Value, by Type (%) (2019-2030)
3.3 Global Implantable Drug Delivery Devices Sales Volume by Type
3.3.1 Global Implantable Drug Delivery Devices Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Implantable Drug Delivery Devices Sales Volume, by Type (2019-2030)
3.3.3 Global Implantable Drug Delivery Devices Sales Volume, by Type (%) (2019-2030)
3.4 Global Implantable Drug Delivery Devices Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Intravenous Chemotherapy
4.1.2 Nutrition Support Therapy
4.2 Global Implantable Drug Delivery Devices Sales Value by Application
4.2.1 Global Implantable Drug Delivery Devices Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Implantable Drug Delivery Devices Sales Value, by Application (2019-2030)
4.2.3 Global Implantable Drug Delivery Devices Sales Value, by Application (%) (2019-2030)
4.3 Global Implantable Drug Delivery Devices Sales Volume by Application
4.3.1 Global Implantable Drug Delivery Devices Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Implantable Drug Delivery Devices Sales Volume, by Application (2019-2030)
4.3.3 Global Implantable Drug Delivery Devices Sales Volume, by Application (%) (2019-2030)
4.4 Global Implantable Drug Delivery Devices Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Implantable Drug Delivery Devices Sales Value by Region
5.1.1 Global Implantable Drug Delivery Devices Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Implantable Drug Delivery Devices Sales Value by Region (2019-2024)
5.1.3 Global Implantable Drug Delivery Devices Sales Value by Region (2025-2030)
5.1.4 Global Implantable Drug Delivery Devices Sales Value by Region (%), (2019-2030)
5.2 Global Implantable Drug Delivery Devices Sales Volume by Region
5.2.1 Global Implantable Drug Delivery Devices Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Implantable Drug Delivery Devices Sales Volume by Region (2019-2024)
5.2.3 Global Implantable Drug Delivery Devices Sales Volume by Region (2025-2030)
5.2.4 Global Implantable Drug Delivery Devices Sales Volume by Region (%), (2019-2030)
5.3 Global Implantable Drug Delivery Devices Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Implantable Drug Delivery Devices Sales Value, 2019-2030
5.4.2 North America Implantable Drug Delivery Devices Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Implantable Drug Delivery Devices Sales Value, 2019-2030
5.5.2 Europe Implantable Drug Delivery Devices Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Implantable Drug Delivery Devices Sales Value, 2019-2030
5.6.2 Asia Pacific Implantable Drug Delivery Devices Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Implantable Drug Delivery Devices Sales Value, 2019-2030
5.7.2 South America Implantable Drug Delivery Devices Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Implantable Drug Delivery Devices Sales Value, 2019-2030
5.8.2 Middle East & Africa Implantable Drug Delivery Devices Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Implantable Drug Delivery Devices Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Implantable Drug Delivery Devices Sales Value
6.2.1 Key Countries/Regions Implantable Drug Delivery Devices Sales Value, 2019-2030
6.2.2 Key Countries/Regions Implantable Drug Delivery Devices Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Implantable Drug Delivery Devices Sales Value, 2019-2030
6.3.2 United States Implantable Drug Delivery Devices Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Implantable Drug Delivery Devices Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Implantable Drug Delivery Devices Sales Value, 2019-2030
6.4.2 Europe Implantable Drug Delivery Devices Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Implantable Drug Delivery Devices Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Implantable Drug Delivery Devices Sales Value, 2019-2030
6.5.2 China Implantable Drug Delivery Devices Sales Value by Type (%), 2023 VS 2030
6.5.3 China Implantable Drug Delivery Devices Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Implantable Drug Delivery Devices Sales Value, 2019-2030
6.6.2 Japan Implantable Drug Delivery Devices Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Implantable Drug Delivery Devices Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Implantable Drug Delivery Devices Sales Value, 2019-2030
6.7.2 South Korea Implantable Drug Delivery Devices Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Implantable Drug Delivery Devices Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Implantable Drug Delivery Devices Sales Value, 2019-2030
6.8.2 Southeast Asia Implantable Drug Delivery Devices Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Implantable Drug Delivery Devices Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Implantable Drug Delivery Devices Sales Value, 2019-2030
6.9.2 India Implantable Drug Delivery Devices Sales Value by Type (%), 2023 VS 2030
6.9.3 India Implantable Drug Delivery Devices Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 BD
7.1.1 BD Company Information
7.1.2 BD Introduction and Business Overview
7.1.3 BD Implantable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
7.1.4 BD Implantable Drug Delivery Devices Product Offerings
7.1.5 BD Recent Development
7.2 B.Braun
7.2.1 B.Braun Company Information
7.2.2 B.Braun Introduction and Business Overview
7.2.3 B.Braun Implantable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
7.2.4 B.Braun Implantable Drug Delivery Devices Product Offerings
7.2.5 B.Braun Recent Development
7.3 AngioDynamics
7.3.1 AngioDynamics Company Information
7.3.2 AngioDynamics Introduction and Business Overview
7.3.3 AngioDynamics Implantable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
7.3.4 AngioDynamics Implantable Drug Delivery Devices Product Offerings
7.3.5 AngioDynamics Recent Development
7.4 Smiths Medical
7.4.1 Smiths Medical Company Information
7.4.2 Smiths Medical Introduction and Business Overview
7.4.3 Smiths Medical Implantable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Smiths Medical Implantable Drug Delivery Devices Product Offerings
7.4.5 Smiths Medical Recent Development
7.5 Teleflex
7.5.1 Teleflex Company Information
7.5.2 Teleflex Introduction and Business Overview
7.5.3 Teleflex Implantable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Teleflex Implantable Drug Delivery Devices Product Offerings
7.5.5 Teleflex Recent Development
7.6 Cook Medical
7.6.1 Cook Medical Company Information
7.6.2 Cook Medical Introduction and Business Overview
7.6.3 Cook Medical Implantable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Cook Medical Implantable Drug Delivery Devices Product Offerings
7.6.5 Cook Medical Recent Development
7.7 Fresenius
7.7.1 Fresenius Company Information
7.7.2 Fresenius Introduction and Business Overview
7.7.3 Fresenius Implantable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Fresenius Implantable Drug Delivery Devices Product Offerings
7.7.5 Fresenius Recent Development
7.8 Vygon
7.8.1 Vygon Company Information
7.8.2 Vygon Introduction and Business Overview
7.8.3 Vygon Implantable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Vygon Implantable Drug Delivery Devices Product Offerings
7.8.5 Vygon Recent Development
7.9 PFM Medical
7.9.1 PFM Medical Company Information
7.9.2 PFM Medical Introduction and Business Overview
7.9.3 PFM Medical Implantable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
7.9.4 PFM Medical Implantable Drug Delivery Devices Product Offerings
7.9.5 PFM Medical Recent Development
7.10 Districlass
7.10.1 Districlass Company Information
7.10.2 Districlass Introduction and Business Overview
7.10.3 Districlass Implantable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Districlass Implantable Drug Delivery Devices Product Offerings
7.10.5 Districlass Recent Development
7.11 Linhwa
7.11.1 Linhwa Company Information
7.11.2 Linhwa Introduction and Business Overview
7.11.3 Linhwa Implantable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Linhwa Implantable Drug Delivery Devices Product Offerings
7.11.5 Linhwa Recent Development
8 Industry Chain Analysis
8.1 Implantable Drug Delivery Devices Industrial Chain
8.2 Implantable Drug Delivery Devices Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Implantable Drug Delivery Devices Sales Model
8.5.2 Sales Channel
8.5.3 Implantable Drug Delivery Devices Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

BD
B.Braun
AngioDynamics
Smiths Medical
Teleflex
Cook Medical
Fresenius
Vygon
PFM Medical
Districlass
Linhwa

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂